These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1872 related items for PubMed ID: 30972740

  • 1. Validation of five patient-reported outcomes for atopic dermatitis severity in adults.
    Silverberg JI, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, Ong PY, Fuxench ZC, Simpson EL.
    Br J Dermatol; 2020 Jan; 182(1):104-111. PubMed ID: 30972740
    [Abstract] [Full Text] [Related]

  • 2. Comparison of Patient-Oriented Eczema Measure and Patient-Oriented Scoring Atopic Dermatitis vs Eczema Area and Severity Index and other measures of atopic dermatitis: A validation study.
    Silverberg JI, Lei D, Yousaf M, Janmohamed SR, Vakharia PP, Chopra R, Chavda R, Gabriel S, Patel KR, Singam V, Kantor R, Hsu DY.
    Ann Allergy Asthma Immunol; 2020 Jul; 125(1):78-83. PubMed ID: 32199977
    [Abstract] [Full Text] [Related]

  • 3. Measurement properties of the Patient-Reported Outcomes Information System (PROMIS® ) Itch Questionnaire: itch severity assessments in adults with atopic dermatitis.
    Silverberg JI, Lai JS, Patel KR, Singam V, Vakharia PP, Chopra R, Sacotte R, Kantor R, Hsu DY, Cella D.
    Br J Dermatol; 2020 Nov; 183(5):891-898. PubMed ID: 32107772
    [Abstract] [Full Text] [Related]

  • 4. Content and construct validity, predictors, and distribution of self-reported atopic dermatitis severity in US adults.
    Silverberg JI, Chiesa Fuxench ZC, Gelfand JM, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, Simpson EL, Ong PY.
    Ann Allergy Asthma Immunol; 2018 Dec; 121(6):729-734.e4. PubMed ID: 30092267
    [Abstract] [Full Text] [Related]

  • 5. Patient burden and quality of life in atopic dermatitis in US adults: A population-based cross-sectional study.
    Silverberg JI, Gelfand JM, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, Simpson EL, Ong PY, Chiesa Fuxench ZC.
    Ann Allergy Asthma Immunol; 2018 Sep; 121(3):340-347. PubMed ID: 30025911
    [Abstract] [Full Text] [Related]

  • 6. Validation of four single-item patient-reported assessments of sleep in adult atopic dermatitis patients.
    Lei D, Yousaf M, Janmohamed SR, Vakharia PP, Chopra R, Chavda R, Gabriel S, Sacotte R, Patel KR, Singam V, Immaneni S, Kantor R, Hsu DY, Silverberg JI.
    Ann Allergy Asthma Immunol; 2020 Mar; 124(3):261-266. PubMed ID: 31830585
    [Abstract] [Full Text] [Related]

  • 7. Validation and Interpretation of Short Form 12 and Comparison with Dermatology Life Quality Index in Atopic Dermatitis in Adults.
    Silverberg JI, Gelfand JM, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, Ong PY, Chiesa Fuxench ZC, Simpson EL.
    J Invest Dermatol; 2019 Oct; 139(10):2090-2097.e3. PubMed ID: 31009616
    [Abstract] [Full Text] [Related]

  • 8. Symptoms and diagnosis of anxiety and depression in atopic dermatitis in U.S. adults.
    Silverberg JI, Gelfand JM, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, Ong PY, Chiesa Fuxench ZC, Simpson EL.
    Br J Dermatol; 2019 Sep; 181(3):554-565. PubMed ID: 30838645
    [Abstract] [Full Text] [Related]

  • 9. Severity strata for POEM, PO-SCORAD, and DLQI in US adults with atopic dermatitis.
    Silverberg JI, Gelfand JM, Margolis DJ, Fonacier L, Boguniewicz M, Schwartz LB, Simpson E, Grayson MH, Ong PY, Fuxench ZCC.
    Ann Allergy Asthma Immunol; 2018 Oct; 121(4):464-468.e3. PubMed ID: 30003968
    [Abstract] [Full Text] [Related]

  • 10. Measurement properties of three assessments of burden used in atopic dermatitis in adults.
    Patel KR, Singam V, Vakharia PP, Chopra R, Sacotte R, Patel N, Immaneni S, Kantor R, Hsu DY, Silverberg JI.
    Br J Dermatol; 2019 May; 180(5):1083-1089. PubMed ID: 30246360
    [Abstract] [Full Text] [Related]

  • 11. Validity and reliability of Patient-Reported Outcomes Measurement Information System Global Health scale in adults with atopic dermatitis.
    Schwartzman G, Lei D, Yousaf M, Janmohamed SR, Vakharia PP, Chopra R, Chavda R, Gabriel S, Patel KR, Singam V, Kantor R, Hsu DY, Silverberg JI.
    J Am Acad Dermatol; 2021 Sep; 85(3):636-644. PubMed ID: 33484762
    [Abstract] [Full Text] [Related]

  • 12. Validation of Patient-Reported Outcomes Information System Sleep Disturbance and Sleep-Related Impairment in adults with atopic dermatitis.
    Lei DK, Yousaf M, Janmohamed SR, Vakharia PP, Chopra R, Sacotte R, Patel KR, Singam V, Immaneni S, Kantor R, Hsu DY, Silverberg JI.
    Br J Dermatol; 2020 Nov; 183(5):875-882. PubMed ID: 32017011
    [Abstract] [Full Text] [Related]

  • 13. Analysis of correlations between patient-oriented SCORAD (PO-SCORAD) and other assessment scores of atopic dermatitis severity and quality of life.
    Coutanceau C, Stalder JF.
    Dermatology; 2014 Nov; 229(3):248-55. PubMed ID: 25196258
    [Abstract] [Full Text] [Related]

  • 14. Assessment of clinical signs of atopic dermatitis: a systematic review and recommendation.
    Schmitt J, Langan S, Deckert S, Svensson A, von Kobyletzki L, Thomas K, Spuls P, Harmonising Outcome Measures for Atopic Dermatitis (HOME) Initiative.
    J Allergy Clin Immunol; 2013 Dec; 132(6):1337-47. PubMed ID: 24035157
    [Abstract] [Full Text] [Related]

  • 15. Longitudinal course and phenotypes of health-related quality of life in adults with atopic dermatitis.
    Schwartzman G, Lei D, Ahmed A, Chavda R, Gabriel S, Silverberg JI.
    Clin Exp Dermatol; 2022 Feb; 47(2):359-372. PubMed ID: 34623642
    [Abstract] [Full Text] [Related]

  • 16. Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2.
    Cork MJ, Eckert L, Simpson EL, Armstrong A, Barbarot S, Puig L, Girolomoni G, de Bruin-Weller M, Wollenberg A, Kataoka Y, Remitz A, Beissert S, Mastey V, Ardeleanu M, Chen Z, Gadkari A, Chao J.
    J Dermatolog Treat; 2020 Sep; 31(6):606-614. PubMed ID: 31179791
    [Abstract] [Full Text] [Related]

  • 17. [Clinical observation on the efficacy and safety of dupilumab in the treatment of moderate to severe atopic dermatitis].
    Li CY, Chen S, Qian WL, Yang L, Zheng Q, Chen AJ, Chen J, Huang K, Fang S, Wang P, Hu L, Liu XR, Zhao XQ, Tan N, Cai T.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Oct 06; 57(10):1590-1595. PubMed ID: 37859375
    [Abstract] [Full Text] [Related]

  • 18. Depression, Anxiety, and Suicidal Ideation in Patients with Atopic Eczema in a Prospective Study in Leipzig, Germany.
    Kage P, Poblotzki L, Zeynalova S, Zarnowski J, Simon JC, Treudler R.
    Int Arch Allergy Immunol; 2022 Oct 06; 183(4):409-414. PubMed ID: 34864728
    [Abstract] [Full Text] [Related]

  • 19. Atopic Dermatitis in US Adults: From Population to Health Care Utilization.
    Silverberg JI, Gelfand JM, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, Ong PY, Chiesa Fuxench Z, Simpson EL.
    J Allergy Clin Immunol Pract; 2019 Oct 06; 7(5):1524-1532.e2. PubMed ID: 30654197
    [Abstract] [Full Text] [Related]

  • 20. Validation of patient-reported global severity of atopic dermatitis in adults.
    Vakharia PP, Chopra R, Sacotte R, Patel N, Immaneni S, White T, Kantor R, Hsu DY, Silverberg JI.
    Allergy; 2018 Feb 06; 73(2):451-458. PubMed ID: 28905999
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 94.